Yüklüyor......
Immunotherapeutic options for Epstein–Barr virus-associated lymphoproliferative disease following transplantation
Epstein–Barr virus-associated lymphoproliferative diseases (EBV-LPD) after hematopoietic stem cell transplantation or solid-organ transplantation remain a serious and potentially life-threatening complication. In the last decade, outcomes for EBV-LPD have significantly improved. Key to this success...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3075565/ https://ncbi.nlm.nih.gov/pubmed/20874650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.43 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|